Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Surprises Stock Declines ATAT Q1 2026 Earnings Strong EPS Beat of 25 Despite Stock Pullback Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances MOMO Q4 2025 Earnings EPS Misses Estimates Shares Decline on Surprise Shortfall BRKRP Q1 2026 Earnings EPS Surpasses Estimates by 3014 as Preferred Holders Await Broader Company Update DTG Q1 2026 Earnings EPS Falls Short of Estimates Following Operational Headwinds